Incyte to Report Second Quarter Financial Results
July 11 2023 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
second quarter financial results conference call and webcast for
8:00 a.m. ET on Tuesday, August 1, 2023.
The schedule for the press release and conference call/webcast
is as follows:
- Q2 2023 Press Release: August 1, 2023 at 7:00 a.m. ET
- Q2 2023 Conference Call: August 1, 2023 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13739925
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13739925.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical
company focused on finding solutions for serious unmet medical
needs through the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte,
please visit Incyte.com and follow @Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230711569566/en/
Incyte Contacts Media
Catalina Loveman +1 302 498 6171 cloveman@incyte.com
Investors Greg Shertzer +1 302 274 4779
gshertzer@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From May 2024 to Jun 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2023 to Jun 2024